Zobrazeno 1 - 10
of 70
pro vyhledávání: '"M. O'Reilly"'
Autor:
Anne M. Noonan, Jeffrey A. Meyerhardt, Erin Twohy, Tanios Bekaii-Saab, Nathan Hall, Briant Fruth, Paul J. Thurmes, David H. Ilson, Fang-Shu Ou, Alan P. Venook, Daniel J. Boffa, Yelena Y. Janjigian, Donna Niedzwiecki, Eileen M. O'Reilly, Karyn A. Goodman, Wendy L. Frankel, Michael O. Meyers, Kisha Mitchell
Publikováno v:
J Clin Oncol
PURPOSE To evaluate the use of early assessment of chemotherapy responsiveness by positron emission tomography (PET) imaging to tailor therapy in patients with esophageal and esophagogastric junction adenocarcinoma. METHODS After baseline PET, patien
Autor:
Vinod P. Balachandran, Wungki Park, Jeffrey A. Drebin, Kenneth Seier, Alice C. Wei, Kenneth H. Yu, Jared Bassmann, Kevin C. Soares, William R. Jarnagin, Christopher H. Crane, Mithat Gonen, Marsha Reyngold, T. Peter Kingham, Joshua S. Jolissaint, Michael I. D’Angelica, Eileen M. O'Reilly, Anna M. Varghese
Publikováno v:
Hepatobiliary Surg Nutr
OBJECTIVE We sought to compare overall survival (OS) and disease control for patients with localized pancreatic ductal adenocarcinoma (PDAC) treated with ablative dose radiotherapy (A-RT) versus resection. SUMMARY BACKGROUND DATA Locoregional treatme
Publikováno v:
Cancer Medicine, Vol 9, Iss 13, Pp 4572-4580 (2020)
Cancer Medicine
Cancer Medicine
Introduction Evidence‐based recommendations on duration of multiagent systemic therapy for LAPC are lacking. Herein, we assess the impact of duration of combination systemic therapy on survival of patients with LAPC. Methods The National Cancer Dat
Autor:
Andrea Cercek, James J. Harding, Ahmet Zehir, Emily Valentino, Maeve A. Lowery, Imane El Dika, Joanne F. Chou, Teresa Rasalan-Ho, Mikaela Bradley, Kenneth H. Yu, Ezra Morgono, Ellen Hollywood, Michael F. Berger, Marinela Capanu, Ghassan K. Abou-Alfa, Philip C. Wong, Ryan Ptashkin, Scott R. Gerst, Erica Salehi, Eileen M. O'Reilly
Publikováno v:
Clinical Cancer Research. 25:937-945
Purpose: Mutations in the RAS/RAF/MEK/ERK signaling pathway are commonly found in biliary tract cancer (BTC). Binimetinib, a selective inhibitor of MEK1/2, has single-agent activity. Preclinical data support binimetinib combination with chemotherapy,
Autor:
Eileen M. O'Reilly, William R. Jarnagin, Joanne F. Chou, Michael I. D’Angelica, Lily V Saadat, T. Peter Kingham, Jeffrey A. Drebin, Mithat Gonen, Alice C. Wei, Kevin C. Soares, Anna M. Varghese
Publikováno v:
Cancer. 127(19)
BACKGROUND Pancreatic cancer is uncommon in patients younger than 50 years, although its incidence is increasing. This study characterizes treatment utilization for early-onset pancreatic cancer (EOPC) versus average-age-onset pancreatic cancer (AOPC
Autor:
Binbin Zheng-Lin, Eileen M. O'Reilly
Regardless of success of immunotherapy in other tumor types, pancreatic ductal adenocarcinoma (PDAC) has remained largely resistant to the benefit of immunotherapy. The unique immune resistance of PDAC arises from multiple non-redundant pathways whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9403a7a907dbfbb56ed155a45ca68129
https://doi.org/10.1007/13905_2021_8
https://doi.org/10.1007/13905_2021_8
Publikováno v:
The Cancer Journal. 23:350-354
Standard palliative doses of radiation for locally advanced unresectable pancreatic cancer have had minimal to no impact on survival. Randomized trials evaluating these palliative doses have not shown a significant survival benefit with the use of ra
Autor:
Ghassan K. Abou-Alfa, Emmet Jordan, William Alago, Eileen M. O'Reilly, David S. Klimstra, Olca Basturk, Jinru Shia, Michael I. D’Angelica, Maeve A. Lowery
Publikováno v:
Journal of Gastrointestinal Oncology. 8:E65-E72
We describe a case of primary acinar cell carcinoma (ACC) originating in the liver in a 54-year-old female, diagnosed following persistent abnormal elevated liver function. Imaging revealed two masses, one dominant lesion in the right hepatic lobe an
Autor:
Lacey J. Kitch, George A. Fisher, Robert A. Wolff, Robert H. Vonderheide, Taylor A. Black, Stephanie S. Yee, Mark H. O'Hara, Andrew H. Ko, Osama E. Rahma, Eileen M. O'Reilly, Zhuoyang Wang, Theresa LaVallee, Cheryl Selinsky, Aseel Abdalla, Pier Federico Gherardini, Erica L. Carpenter, Zev A. Wainberg, Jacob Till, Jaclyn P. Lyman, Neha Bhagwat
Publikováno v:
Journal of Clinical Oncology. 39:4122-4122
4122 Background: Traditional imaging-guided therapeutic decision-making for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) may lag and, on occasion, be misleading. The concept of liquid biopsy-based molecular response holds promise
Publikováno v:
Cancer. 122:3765-3775
Of the anticipated 50,000 individuals expected to be diagnosed with pancreatic cancer in 2016, the majority will have metastatic disease. Given the noncurative nature of advanced pancreatic adenocarcinoma, treatment is aimed at inducing disease regre